Wave Life Sciences (WVE) Change in Accured Expenses (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Change in Accured Expenses data on file, last reported at $5.2 million in Q2 2026.

• Quarterly Change in Accured Expenses changed 0.27% year-over-year to $5.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $5.2 million (up 122.05% YoY) and the FY2025 annual result came in at $5.5 million, up 28.92% from the prior year.
• Change in Accured Expenses rose to $5.2 million in Q2 2026, from -$13.5 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $10.1 million in Q4 2025 to a low of -$13.5 million in Q1 2026.
• A 5-year average of $187833.3 and a median of $3.5 million in 2024 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 102.01% — and 2023, when it jumped 7668.97%.
• Tracing WVE's Change in Accured Expenses over 5 years: stood at $6.5 million in 2022, then tumbled by 35.28% to $4.2 million in 2023, then jumped by 65.06% to $6.9 million in 2024, then surged by 45.22% to $10.1 million in 2025, then sank by 48.41% to $5.2 million in 2026.
• The last three Change in Accured Expenses figures came in at $5.2 million (Q2 2026), -$13.5 million (Q1 2026), and $10.1 million (Q4 2025), per Business Quant data.